Home › Liver Diseases › Arizona
Liver Diseases clinical trials in Arizona
5 studies for Liver Diseases are looking for participants at sites in Arizona.
Cities in Arizona
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Arizona Liver Health, Chandler
- Arizona Liver Health - Peoria, Peoria
- Adobe Clinical Research, LLC, Tucson
- and 1 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 9, 2026 · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chandler
- 89bio Clinical Study Site, Glendale
- 89bio Clinical Study Site, Sun City
- and 2 more
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Chandler
- 89bio Clinical Study Site, Peoria
- 89bio Clinical Study Site, Phoenix
- and 4 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Clinical Trial Site, Phoenix
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT06600321A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
- Arizona Clinical Trials - the Institute For Liver Health, Chandler
RecruitingPhase 1
Ages 18 to 80 · All sexes · Updated Jun 16, 2026 · NCT07559474From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.